Demographics |
Age, sex, gender, education/income level, ethnicity,
employment |
Medical and health history |
Previous genetic testing, hereditary
conditions, autoimmune/inflammatory conditions, diabetes (type 1/2),
hepatic/renal/cardiac/lung issues, gastrointestinal disorders, cancer,
neurological or neuromuscular disorders, blood/iron disorders, viral
infections, blood pressure, body mass index, smoking habits, diet,
medications |
COVID-19 symptoms and vaccination status |
Symptom type (e.g. cough,
sore throat) as well as date of onset and duration, type (e.g. Pfizer)
and number of vaccine doses, date of dose and resulting onset/duration
of post-vaccination symptoms (if applicable), hospitalization status and
emergency department admission |
Knowledge and health outcomes |
Knowledge questions pertaining to GS and
COVID-19 serology, satisfaction with decision pertaining to GS
information, attitudes toward genetics and healthcare, generalized
hospital anxiety and depression and quality of life
scales |
Participant preferences |
Initial preferences for learning COVID-19
serology results and SF from GS |